Check the time stamp on this data. Updated AI-Generated Signals for Nurix Therapeutics Inc. (NRIX) available here: NRIX. Type ...

Check the time stamp on this data. Updated AI-Generated Signals for Nurix Therapeutics Inc. (NRIX) available here: NRIX. Type ...

Investors in Nurix Therapeutics Inc (Symbol: NRIX) saw new options begin trading this week, for the March 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Barclays analyst Peter Lawson maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report) today and set a price target of $31.00.

For example, Nurix Therapeutics (NASDAQ:NRIX) shareholders have done very well over the last year, with the share price soaring by 135%. But while the successes are well known, investors should ...

NRIX opened at $19.68 on Tuesday. The firm has a market capitalization of $1.39 billion, a P/E ratio of -6.76 and a beta of 2.14. The firm’s 50 day moving average is $20.65 and its 200-day ...

Just because a business does not make any money, does not mean that the stock will go down. For example, Nurix Therapeutics (NASDAQ:NRIX) shareholders have done very well over the last year, with the ...

$NRIX insiders have traded $NRIX stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales. Here’s a ...

Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like NX-5948. The company’s DELigase platform allows for targeted protein ...